Valuation : Biosynex

Market Cap 16.22M 18.85M 15.22M 13.93M 25.99M 1.78B 26.2M 180M 70.12M 911M 70.79M 69.25M 2.93B P/E 2024
-0.43x
P/E 2025 -0.19x
Enterprise Value 69.41M 80.67M 65.14M 59.59M 111M 7.63B 112M 771M 300M 3.9B 303M 296M 12.55B EV / Sales 2024
0.71x
EV / Sales 2025 0.68x
Free-Float
40.35%
Yield 2024 *
-
Yield 2025 -
1 day+0.23%
1 week-4.13%
Current month-1.78%
1 month-4.13%
3 months-4.13%
6 months+3.76%
Current year+47.99%
1 week 0.81
Extreme 0.808
0.92
1 month 0.81
Extreme 0.808
1
Current year 0.56
Extreme 0.564
1.57
1 year 0.46
Extreme 0.455
1.57
3 years 0.46
Extreme 0.455
10.9
5 years 0.46
Extreme 0.455
28.78
10 years 0.46
Extreme 0.455
30.38
Manager TitleAgeSince
Chief Executive Officer 71 24/06/2015
Chief Tech/Sci/R&D Officer 63 01/01/2015
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 63 24/06/2015
Director/Board Member - 24/06/2015
Chairman 71 24/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
15/2/23 Buy

Director

2,500 0.0244%
15/2/23 Buy

Director

2,500 0.0244%
28/2/22 Buy

Chief Executive Officer

2,000 0.0180%
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-4.13%-24.62%-91.83% 18.8M
-1.41%-4.94%+146.22%+353.67% 21.88B
+0.46%+0.60%-35.58%-20.60% 10.31B
+1.22%-4.21%+365.64%+18.36% 8.03B
0.00%-6.48%-32.96% - 7.01B
+0.06%+0.39%+82.88%+52.70% 6.58B
-0.65%-2.39%-19.20%-20.52% 5.92B
+0.50%-0.31%-9.97%-20.34% 4.38B
-0.26%+1.36%+73.96%+83.74% 4.26B
-0.42%-1.38%-19.61%-27.96% 2.8B
Average -0.07%-2.03%+52.68%+36.36% 7.12B
Weighted average by Cap. -0.35%-2.65%+86.88%+125.98%

Financials

2024 2025
Net sales 101M 118M 94.94M 86.86M 162M 11.12B 163M 1.12B 437M 5.68B 442M 432M 18.29B 95.19M 111M 89.33M 81.73M 153M 10.46B 154M 1.06B 412M 5.34B 415M 406M 17.21B
Net income -43.33M -50.36M -40.66M -37.2M -69.44M -4.76B -69.99M -481M -187M -2.43B -189M -185M -7.84B -58.22M -67.67M -54.64M -49.99M -93.3M -6.4B -94.04M -646M -252M -3.27B -254M -249M -10.53B
Net Debt 52.94M 61.52M 49.68M 45.45M 84.83M 5.82B 85.5M 588M 229M 2.97B 231M 226M 9.57B 53.19M 61.82M 49.91M 45.67M 85.24M 5.84B 85.91M 590M 230M 2.99B 232M 227M 9.62B
Logo Biosynex
Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.
Employees
397
Date Price Change Volume
04/09/26 EUR 0.8820 +0.23% 2,792
02/09/26 EUR 0.8800 -1.57% 19,500
01/09/26 EUR 0.8940 -0.45% 6,413
31/08/26 EUR 0.8980 -0.22% 2,129
28/08/26 EUR 0.9000 -2.17% 3,237
  1. Stock Market
  2. Stocks
  3. ALBIO Stock